In an open-label phase 3b trial, the co-administration of Lilly’s IL-17A antagonist Taltz (ixekizumab) and dual GIP/GLP-1 ...
The TOGETHER-PsA study shows that combining ixekizumab with tirzepatide leads to significantly better psoriatic arthritis ...
The Oklahoma Corporation Commission approves PSO’s request to purchase a power plant in Jenks. PSO first asked OCC to buy the Green Country Power Plant from Tokyo-based J-Power back in September. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback